Contineum Therapeutics, Inc. CTNM · Insights

website

Contineum Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing of s...

Price10.3

Market Cap404.44 M

Float39.09 M

CountryUS

SectorHealthcare

ExchangeNASDAQ

Overview Filings Insights Dilution News Transcripts

Search in Documents

Open in Studio Login

Key Dates & Timelines

Form Type

Date

Description

Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro

Financial Transactions

Form Type

Date

Description

Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro